Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Accuray To Purchase Morphormics For Around $5.7 Mln - Quick Facts

RELATED NEWS
Trade ARAY now with 
7/16/2012 8:40 AM ET

Accuray Inc. (ARAY: Quote) said it has signed a definitive agreement to acquire Morphormics, Inc., a privately held company which develops medical imaging software systems that automatically recognize and extract anatomical structures from medical images. The agreement provides that Accuray will pay about $5.7 million.

According to Accuray, with the acquisition of Morphormics, it plans to extend autocontouring capabilities for both the CyberKnife Robotic Radiosurgery System and the TomoTherapy System to improve disease specific workflows.

Click here to receive FREE breaking news email alerts for Accuray Incorporated and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Analog Devices, Inc. said that its second quarter profit rose slightly from last year, helped mainly by lower income tax expenses even as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations. However, the company forecast third quarter revenue and earnings below analysts' current consensus estimates. While buying interest was relatively subdued, stocks moved modestly higher over the course of the trading day on Tuesday. The strength on the day offset the weakness seen in the previous session, with the Dow and the S&P 500 reaching new record closing highs. The major averages gave back some ground in late-day trading but remained in positive territory. While a recent series of scandals have caused headaches for the White House, the results of a Washington Post-ABC News poll released Tuesday suggest that the news has not had an impact on President Barack Obama's approval rating. The poll showed that 51 percent of Americans approve of the way Obama is handling his job as president compared to 44 percent that disapprove.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.